Who is sponsoring NCT05091359?

NCT05091359 is sponsored by Hospital Regional Tlalnepantla.

What condition does NCT05091359 study?

NCT05091359 studies Proximal Femur Fracture.

Is NCT05091359 still recruiting?

NCT05091359 is currently completed. Last updated 25 October 2021.

Last reviewed 2021-10-25 · How we verify

NCT05091359: geneX

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Femur Transtrochanteric Fractures Treated With Dynamic Hip Screw and Calcium Sulfate Scaffold.

Completed NA Last updated 25 October 2021

What this trial tests

NA trial testing Study group with absorbable graft of tricalcium ß phosphate / calcium sulfate hemihydrate paste in Proximal Femur Fracture in 36 participants. Completed in 10 May 2019.

Timeline

1 April 2015

Primary endpoint
1 June 2018

10 May 2019

Quick facts

Lead sponsor	Hospital Regional Tlalnepantla
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	36
Start date	1 April 2015
Primary completion	1 June 2018
Estimated completion	10 May 2019

Drugs / interventions tested

Study group with absorbable graft of tricalcium ß phosphate / calcium sulfate hemihydrate paste

Conditions studied

Proximal Femur Fracture — all drugs for Proximal Femur Fracture →

Sponsor

Hospital Regional Tlalnepantla

Who can join

Adults 65 to 80, any sex, with Proximal Femur Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomised prospective comparison study to evaluate the incidence of cut - out failure of the dynamic hip screw implant alone compared to the dynamic hip screw adding calcium sulfate through the cervical canal before placing the sliding screw for improvement of the implant stability integration and bone healing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Proximal Femur Fracture

Currently open trials in the same condition.

NCT07481188 — Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery · recruiting
NCT06396884 — Hemodynamic Optimization During Spinal Anesthesia in the Elderly · recruiting

Other Hospital Regional Tlalnepantla trials

Trials by the same sponsor.

NCT05450458 — Hyaluronic Acid in Overuse Knee Pain · Phase 2, PHASE3 · completed
NCT03976466 — Prophylaxis of Periprosthetic Joint Infections With Calcium Sulfate Beads in Patients With Non-modifiable Risk Factors. · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05091359 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Regional Tlalnepantla
Last refreshed: 25 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05091359.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing